Overview
Proxima Pharma is the exclusive distributor in Poland for the French company LCA Pharmaceuticals and a source of its original orthopedic products. Its portfolio includes intra-articular sodium hyaluronate preparations such as Arthrum Visc 75, Arthrum 2.5%, Arthrum H and Synovium HCS, used in conditions including osteoarthritis and knee-joint inflammation.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $573 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 41 days late).
- 2025filed
- 202426/06/2025
- 202326/06/2024
- 202222/06/2023
- 202125/08/2022
- 202006/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Manufacture of basic pharmaceutical products (21.1)
Offer
- Hyaluronic acid preparations
- Medical injection products
- Preparations for osteoarthritis treatment
Website technology
- Analytics and marketing
- Google Analytics
Authorized Representatives
Manner of representation
Each member of the management board is entitled to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Radosław Tomasz Kozłowskiage 52 | 55 | $7,428.42 | 55% |
Mirosław Jan Piecuchage 61 | 45 | $6,077.80 | 45% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2008-06-10.
92 1050 1025 1000 0090 7515 6928
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 11, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $13,847$13,847 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| IMC Impomed CentrumS.A. | $4,447,564.10 | impomed.pl | ||
| Gtm-Mobil M-T T.Walisiewiczsp. k. | $3,438,533.82 | gtmmobil.com.pl | ||
| Reynolds Medicalsp. z o.o. | $3,313,657.78 | reymed.pl | ||
| Petronafsp. z o.o. | $2,499,010.09 | petronaf.com | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-01-14 | PKD change (Removed: 47 codes; Added: 5 codes) | |
| 2014-11-06 | Address change (Suchogórska 59, 41-936, Bytom → Chmielna 2/31, 00-020, Warszawa) | |
| 2010-04-29 | Address change (Zabrzańska 119, 41-907, Bytom → Suchogórska 59, 41-936, Bytom) | |
| 2010-04-29 | PKD change (Added: 37 codes) | |
| 2008-06-25 | Entered in the register |
FAQ
Last updated: 2026-10-07